Journal Report

European Heart Journal - Cardiovascular Pharmacotherapy

Download PDF
Journal Information
Journal Title
European Heart Journal - Cardiovascular Pharmacotherapy
Publisher
Oxford University Press
ISSN
2055-6837
E-ISSN
2055-6845
Database
SCOPUS
Domain
Health Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction <i>:</i> A Target Trial Emulation Study
George Frederick Mkoma, Anders Hviid, Björn Pasternak et al.
2026-10-26
DOI: 10.1093/ehjcvp/pvag094
ESC Congress 2026 Antithrombotic Highlights: Balancing Ischemic and Bleeding Risk After Percutaneous Intervention
Neel Koyawala, Deepak L Bhatt
2026-10-26
DOI: 10.1093/ehjcvp/pvag093
Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial
Mariëlle Scheffer, Willemijn van Maarschalkerwaart, Chaohui Dong et al.
2026-10-17
DOI: 10.1093/ehjcvp/pvag091
Repositioning Vericiguat after VICTOR: Towards a Risk- and Timing-Based Framework in Contemporary HFrEF
Teruhiko Imamura
2026-10-14
DOI: 10.1093/ehjcvp/pvag092
Nebivolol for the prevention of left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy: the NEBIDYS trial
Luca Monzo, Henri-Marc Becane, Yves Dulac et al.
2026-10-7
DOI: 10.1093/ehjcvp/pvag090
Refining cardiovascular pharmacotherapy in cardio-oncology and cardiac amyloidosis: news from ESC Congress 2026
Massimiliano Camilli, Marianna Fontana, Pietro Ameri
2026-10-7
DOI: 10.1093/ehjcvp/pvag088
Same target but different bleeding outcomes: insights from a randomized apixaban-rivaroxaban comparison in patients with acute venous thromboembolism
Jean-Luc Reny, Youssef Daali, Jean Terrier
2026-10-7
DOI: 10.1093/ehjcvp/pvag087
Analysis and interpretation of a hierarchical outcome in a small pilot randomized trial: an example in the CORTAHF trial
Jan Biegus, Christopher Edwards, Gary Koch et al.
2026-10-7
DOI: 10.1093/ehjcvp/pvag089
The LIBREXIA-ACS trial: new fuel for debate?
Renske H Olie, Jurrien ten Berg, Hugo ten Cate
2026-10-5
DOI: 10.1093/ehjcvp/pvag085
Statins for primary prevention in the elderly
Jessica Schubert, Margrét Leósdóttir
2026-9-30
DOI: 10.1093/ehjcvp/pvag082
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 28, 2026 13:16